このエントリーをはてなブックマークに追加
ID 34995
本文ファイル
著者
Kenjo, Masahiro
Kobatake, Kohei
Iwamoto, Hideo
Goriki, Akihiro
Oki, Mami
Shoji, Koichi
Miyamoto, Katsutoshi
Masumoto, Hiroshi
Kobayashi, Kanao
Ohara, Shinya
Murakami, Yuji
Kaneyasu, Yuko
キーワード
Brachytherapy
Localized prostate cancer
Iodine-125 seed
NDC
医学
抄録(英)
This report presents the outcome of prostate permanent brachytherapy (PPB). One hundred and seventy-two patients with clinically localized prostate cancer were treated with permanent brachytherapy using iodine-125 seeds (125-I) at Hiroshima University Hospital from July 2004 to June 2010. This study evaluated the efficacy of PPB in these patients. The median patient age was 69 years (range 53 to 82 years), the median prostate-specific antigen (PSA) value before biopsy was 6.75 ng/ml (range 3.5 to 47.9 ng/ml), and the median prostate volume was 23.1 ml (range 10.1 to 57 ml). The median follow-up was 37 months (range 1 to 72 months). The serum PSA levels decreased continuously after PPB throughout the entire follow-up period in 97% of patients without neoadjuvant hormonal therapy. No relapse occurred during the follow-up period in patients at low risk. Our 6-year experience suggests that PPB is effective for localized prostate cancer. Patients with prostate cancer that does not require combined External beam radiation therapy (EBRT) have the best chance of responding to treatment.
掲載誌名
Hiroshima Journal of Medical Sciences
60巻
3号
開始ページ
51
終了ページ
56
出版年月日
2011-09
出版者
Hiroshima University Medical Press
ISSN
0018-2052
NCID
言語
英語
NII資源タイプ
紀要論文
広大資料タイプ
学内刊行物(紀要等)
DCMIタイプ
text
フォーマット
application/pdf
著者版フラグ
publisher
権利情報
(c) Hiroshima University Medical Press.
部局名
医歯薬学総合研究科
他の一覧